Many investors have become quite frustrated by the stock markets’ performance relative to their own portfolio performance. 2024 is one of those years whereby most stocks are underperforming the indices themselves, and by a great deal. It’s a stock market year, not a stock picker’s year. In truth, it’s been that way for the last 18 months now. If you…
Ready… Or Not; Data-Driven Fed Holds The Cards
A financial market resource for the every-day investor and trader.
-
Goldman Sachs Tactical Flow-of-Funds: August – On Correction Watch
Seth Golden, , Research Reports, 0
Scott Rubner, Managing Director Goldman Sachs This is the last bullish US Equity email that I will be sending...
-
-
Capital Economics: Soft landings, immaculate disinflation, and US equities
Seth Golden, , Research Reports, 0
A “soft landing” for the economy in the US seems increasingly possible, so we look back at previous similar episodes...
-
Morgan Stanley’s Weekly Warm-up: Inflation Data and Fed Is Yesterday’s News; Focus on Earnings Risk
Seth Golden, , Research Reports, 0
This week’s focus is likely to be centered on CPI and the Fed. To us, that is yesterday’s news;...
-
Fitbit Finds Itself Restructuring Through 2017
Seth Golden, , Research Reports, 0
What can you say about Fitbit’s (FIT) executive team other than “Wow”? After lowering FY16 guidance upon missing Q3...
-
The J.P. Morgan View: Earnings estimates appear too optimistic
Seth Golden, , Research Reports, 0
Cross-Asset Strategy: US Q2 reporting delivered soft earnings growth and less upbeat corporate guidance, as corporates are seeing demand...
-
Morgan Stanley Weekly Warm-up: Feedback to our Mid Year Outlook
Seth Golden, , Research Reports, 0
While there is some sympathy for our mid-cycle transition, most think it’s too early, or not worth acting on....
-
Like Life, The Markets Have Good Times & Bad Times
Seth Golden, , Research Reports, 3
With ten trading sessions of the New Year complete, January and 2021 are off to a modest start. The...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00